Congressional trading
Who in Congress traded MRK?
Merck & Company, Inc. Common Stock (new) · classified as Health care. 22 disclosed transactions across 10 members.
22
Transactions
10
Members
9 / 13
Buys / sells
5
Filed late
Committee overlap
1 of 10 members who traded MRK sits on a committee with jurisdiction over Health care. This is a disclosed structural overlap, not evidence of wrongdoing. Nothing here asserts that any member acted on non-public information. Jurisdiction is mapped from published House and Senate committee rules — see the methodology.
Members
5 transactions- Sell2025-12-18$1,001 - $15,000(Joint)disclosed after 18dfiling
- Partial sell2025-11-13$1,001 - $15,000(Joint)disclosed after 22dfiling
- Partial sell2025-08-14$1,001 - $15,000(Joint)disclosed after 19dfiling
- Buy2025-06-13$1,001 - $15,000(Joint)disclosed after 26dfiling
- Buy2025-01-17$1,001 - $15,000(Joint)disclosed after 25dfiling
4 transactions
3 transactions
2 transactions1 filed past the 45-day deadline
2 transactions1 filed past the 45-day deadline
2 transactions1 filed past the 45-day deadline
1 transactionCommittee overlap1 filed past the 45-day deadline- Sell2026-03-27$15,001 - $50,000disclosed after 116dfiling
1 transaction1 filed past the 45-day deadline- Sell2025-03-19$15,001 - $50,000(Spouse)disclosed after 145dfiling
1 transaction- Sell2025-01-16$1,001 - $15,000(Spouse)disclosed after 14dfiling
1 transaction- Sell2024-09-24$15,001 - $50,000(Joint)disclosed after 7dfiling
Where this comes from
21 transactions from House Clerk Periodic Transaction Reports and 1 from Senate eFD filings. Amounts are the statutory brackets filers report — Congress does not disclose exact values. Senate filings carry one filing date per report rather than per transaction, so “disclosed after” for a Senate row is measured to the date the whole report was filed. This page is a conflict-of-interest disclosure, not investment advice or a trading signal.